Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN

NCT06186479 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-induced Polyneuropathy

Interventions

DRUG: Aconite pain oil
DRUG: Placebo

Sponsor

WALA Heilmittel GmbH